A single center experience with the HeartMate II™ Left Ventricular Assist Device (LVAD)

Scandinavian Cardiovascular Journal

Volumn 43, Issue 6, 2009, Pages 360-365

  Granfeldt, Hans ^a   Peterzén, Bengt ^a   Hübbert, Laila ^a   Jansson, Kjell ^a   Ahn, Henrik ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bridge to transplantation; Left ventricular assist; Terminal heart failure

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; EMBOLISM; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HEARTMATE II; HOSPITAL DISCHARGE; HUMAN; IMPLANTATION; INOTROPISM; MALE; MORTALITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; SURVIVAL RATE;

ADULT; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 72049102890     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430903019553     Document Type: Article

References (23)

1. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;/ 365(9474):/1877-89.
2. Badhwar V, Bolling SF. Nontransplant surgical options for heart failure. In: Cohn LH, Edmunds LH Jr, editors. Cardiac surgery in the adult. New York: McGraw-Hill; 2003. p. 1515-26.
3. Barr ML, Bourge RC, Orens JB, McCurry KR, Ring WS, Hulbert-Shearon TE, et al. Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant. 2005;/5 (4 Pt 2):/934-49.
4. Murali S. Mechanical circulatory support with the Novacor LVAS: Worldwide clinical results. Thorac Cardiovasc Surg. 1999;/47(Suppl 2):/321-5.
5. El-Banayosy A, Deng M, Loisance DY, Vetter H, Gronda E, Loebe M, et al. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: A retrospective multi-center study. Eur J Cardiothorac Surg. 1999;/15:/835-41.
6. El-Banayosy A, Arusoglu L, Kizner L, Tenderich G, Minami K, Inoue K, et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: A prospective study. J Thorac Cardiovasc Surg. 2000;/119:/581-7.
7. Frazier OH, Rose EA, Oz MC, Dembitsky WP, McCarthy PM, Radovancevic B, et al. Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. J Heart Lung Transplant. 2001;/20:/201-2.
8. Morgan JA, John R, Rao V, Weinberg AD, Lee BJ, Mazzeo PA, et al. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg. 2004;/127:/1309-16.
9. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: Third annual report-2005. J Heart Lung Transplant. 2005;/24:/1182-7.
10. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;/345:/1435-43.
11. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;/ 357:/885-96.
12. Dowling RD, Park SJ, Pagani FD, Tector AJ, Naka Y, Icenogle TB, et al. HeartMate VE LVAS design enhan cements and its impact on device reliability. Eur J Cardiothorac Surg. 2004;/25:/958-63.
13. Frazier OH, Shah NA, Myers TJ, Robertson KD, Gregoric ID, Delgado R. Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology. 2004;/101:/111-6.
14. DeBakey ME, Teitel ER. Use of the MicroMed DeBakey VAD for the treatment of end-stage heart failure. Expert Rev Med Devices. 2005;/2:/137-40.
15. Schmid C, Tjan TD, Etz C, Schmidt C, Wenzelburger F, Wilhelm M, et al. First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant. 2005;/24:/ 1188-1194
16. Tsukui H, Abla A, Teuteberg JJ, McNamara DM, Mathier MA, Cadaret LM, et al. Cerebrovascular accidents in patients with a ventricular assist device. J Thorac Cardiovasc Surg. 2007;/134:/114-23.
17. Mendoza DD, Cooper HA, Panza JA. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J. 2007;/153:/366-70.
18. Letsou GV, Connelly JH, Delgado III RM, Myers TJ, Gregoric ID, Smart FW, et al. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant. 2006;/25:/395-9.
19. Williams M, Casher J, Joshi N, Hankinson T, Warren M, Oz M, et al. Insertion of a left ventricular assist device in patients without thorough transplant evaluations: A worthwhile risk? J Thorac Cardiovasc Surg. 2003;/126:/436-41.
20. Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant. 2005;/24:/200-4.
21. Hoshi H, Shinshi T, Takatani S. Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs. 2006;/30:/324-38.
22. Houghton P. Living with the Jarvik 2000: A five-plus year experience. Artif Organs. 2006;/30:/322-3.
23. Westaby S, Frazier OH, Banning A. Six years of continuous mechanical circulatory support. N Engl J Med. 2006;/355:/ 325-327